Total Payments
$7,511
2024 Payments
$178.25
Companies
48
Transactions
517
Medicare Patients
3,606
Medicare Billing
$271,160
Payment Breakdown by Category
Food & Beverage$7,317 (97.4%)
Education$193.83 (2.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,317 | 514 | 97.4% |
| Education | $193.83 | 3 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $851.06 | 58 | $0 (2024) |
| GlaxoSmithKline, LLC. | $777.32 | 77 | $0 (2023) |
| Amgen Inc. | $667.33 | 50 | $0 (2022) |
| Novo Nordisk Inc | $651.03 | 52 | $0 (2023) |
| PFIZER INC. | $510.91 | 45 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $483.97 | 16 | $0 (2023) |
| Lilly USA, LLC | $387.54 | 30 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $383.77 | 26 | $0 (2022) |
| Astellas Pharma US Inc | $368.95 | 15 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $239.09 | 18 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $178.25 | 3 | Abbott Laboratories ($91.47) |
| 2023 | $692.39 | 40 | AbbVie Inc. ($284.05) |
| 2022 | $1,241 | 80 | Novo Nordisk Inc ($263.67) |
| 2021 | $1,324 | 97 | AbbVie Inc. ($256.61) |
| 2020 | $992.26 | 66 | AstraZeneca Pharmaceuticals LP ($154.24) |
| 2019 | $952.94 | 70 | GlaxoSmithKline, LLC. ($152.59) |
| 2018 | $699.28 | 60 | GlaxoSmithKline, LLC. ($174.64) |
| 2017 | $1,431 | 101 | Lilly USA, LLC ($165.24) |
All Payment Transactions
517 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/08/2024 | Abbott Laboratories | AMPLATZER PICCOLO (Device) | Food and Beverage | In-kind items and services | $91.47 | General |
| Category: Structural Heart | ||||||
| 03/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: NEUROSCIENCE | ||||||
| 02/27/2024 | InSightec,Inc | Exablate (Device) | Food and Beverage | Cash or cash equivalent | $72.46 | General |
| Category: Neurology | ||||||
| 10/03/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: NEUROSCIENCE | ||||||
| 09/27/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: NEUROSCIENCE | ||||||
| 09/15/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: NEUROSCIENCE | ||||||
| 08/30/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2023 | Impulse Dynamics (USA) Inc. | OPTIMIZER (Device), OPTIMIZER | Food and Beverage | Cash or cash equivalent | $23.25 | General |
| Category: Cardiovascular Device | ||||||
| 07/28/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.08 | General |
| Category: NEUROSCIENCE | ||||||
| 07/08/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.82 | General |
| Category: NEUROSCIENCE | ||||||
| 06/13/2023 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: VACCINES | ||||||
| 06/01/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Diabetes Care | ||||||
| 05/20/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: NEUROSCIENCE | ||||||
| 05/12/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: NEUROSCIENCE | ||||||
| 05/05/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: NEUROSCIENCE | ||||||
| 05/04/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.72 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2023 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 04/24/2023 | InSightec,Inc | Exablate (Device) | Food and Beverage | Cash or cash equivalent | $77.18 | General |
| Category: Neurology | ||||||
| 04/11/2023 | Merck Sharp & Dohme LLC | STEGLATRO (Drug), BELSOMRA | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/06/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/06/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.74 | General |
| Category: NEUROSCIENCE | ||||||
| 04/03/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: NEUROSCIENCE | ||||||
| 03/31/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: NEUROSCIENCE | ||||||
| 03/31/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 629 | 762 | $92,488 | $33,715 |
| 2022 | 12 | 1,073 | 1,601 | $188,902 | $86,609 |
| 2021 | 11 | 952 | 1,518 | $169,208 | $84,677 |
| 2020 | 10 | 952 | 1,450 | $145,028 | $66,159 |
Total Patients
3,606
Total Services
5,331
Medicare Billing
$271,160
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 253 | 338 | $43,602 | $13,212 | 30.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 143 | 184 | $33,672 | $11,308 | 33.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 20 | 20 | $6,000 | $5,609 | 93.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 17 | 17 | $2,550 | $2,168 | 85.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 19 | 19 | $760.00 | $572.85 | 75.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 87 | 88 | $4,752 | $546.79 | 11.5% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 90 | 96 | $1,152 | $298.56 | 25.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 372 | 714 | $92,106 | $37,046 | 40.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 206 | 361 | $66,063 | $30,379 | 46.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 31 | 31 | $4,650 | $4,083 | 87.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 58 | 58 | $4,350 | $3,975 | 91.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 14 | 14 | $4,200 | $3,893 | 92.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 17 | 17 | $3,145 | $2,880 | 91.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 60 | 60 | $2,400 | $1,760 | 73.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 147 | 156 | $8,424 | $1,318 | 15.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 18 | 18 | $700.00 | $529.32 | 75.6% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2022 | 126 | 140 | $1,680 | $438.55 | 26.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 11 | 19 | $684.00 | $185.17 | 27.1% |
| 90471 | Administration of vaccine | Office | 2022 | 13 | 13 | $500.00 | $121.00 | 24.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 351 | 718 | $80,160 | $39,490 | 49.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 210 | 393 | $67,245 | $33,675 | 50.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 27 | 27 | $3,975 | $3,598 | 90.5% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 28 | 28 | $2,100 | $1,827 | 87.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 11 | 11 | $2,035 | $1,700 | 83.5% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 11 | 11 | $1,620 | $1,361 | 84.0% |
About Dr. John Daniel, M.D
Dr. John Daniel, M.D is a Internal Medicine healthcare provider based in Richmond, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427007996.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Daniel, M.D has received a total of $7,511 in payments from pharmaceutical and medical device companies, with $178.25 received in 2024. These payments were reported across 517 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($7,317).
As a Medicare-enrolled provider, Daniel has provided services to 3,606 Medicare beneficiaries, totaling 5,331 services with total Medicare billing of $271,160. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Richmond, VA
- Active Since 05/10/2006
- Last Updated 07/16/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1427007996
Products in Payments
- TRELEGY ELLIPTA (Drug) $332.87
- UBRELVY (Drug) $289.16
- Ozempic (Drug) $277.23
- JARDIANCE (Drug) $252.07
- FARXIGA (Drug) $243.21
- EVENITY (Biological) $213.91
- VRAYLAR (Drug) $200.47
- CHANTIX (Drug) $169.67
- TRADJENTA (Drug) $163.95
- QULIPTA (Drug) $158.58
- MYRBETRIQ (Drug) $157.62
- TOUJEO (Drug) $150.43
- Exablate (Device) $149.64
- Rybelsus (Drug) $149.40
- Repatha (Biological) $147.90
- Vascepa (Drug) $143.50
- Prolia (Biological) $142.02
- Aimovig (Biological) $141.05
- ELIQUIS (Drug) $139.81
- TRULICITY (Drug) $134.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Richmond
Dr. George Vetrovec, M.d, M.D
Internal Medicine — Payments: $3.2M
Internal Medicine $3.2M
Dr. Arun Sanyal, M.d, M.D
Internal Medicine — Payments: $956,666
Internal Medicine $956,666
Dr. Erica Gregonis, Md, MD
Internal Medicine — Payments: $314,689
Internal Medicine $314,689
Dr. Lawrence Schwartz, M.d, M.D
Internal Medicine — Payments: $205,580
Internal Medicine $205,580
Dr. Wally Smith, M.d, M.D
Internal Medicine — Payments: $195,657
Internal Medicine $195,657
Dr. Gaurav Gupta, Md, MD
Internal Medicine — Payments: $189,406
Internal Medicine $189,406